Deficit Hawks Suggest Capping Drug Prices In Medicare Parts B & D

By Gabrielle Wanneh / February 22, 2021 at 8:01 PM
The Center for a Responsible Federal Budget wants the Senate to consider capping Medicare Parts B and D drug prices at the rate of inflation to pay for the increased ACA tax credits included in pandemic-relief legislation that they said don’t have to do with the pandemic. According to CRFB, capping drug prices in Parts B and D would offset $80 billion of the $312 billion cost of measures in the House pandemic relief bill that are outside the cost...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.